
| Jackson Nickerson |
| Media Assistance:
Shula Neuman Director, News and Information, Olin Business School and Department of Economics sneuman@wustl.edu (314) 935-5202 |
![]() |
| Jackson Nickerson |
|
|
| News Stories & Tip Sheets: |
|
Showing Stories 1 through 5 of 7. - Show More |
| Business research in practice Washington University in St. Louis awards first Olin Award for most applicable research (http://news-info.wustl.edu/news/page/normal/11495.html) April 7, 2008 -- Two professors at the Olin Business School are the winners of the first annual "Olin Award: Recognizing Research that Transforms Business." Jackson Nickerson, Ph.D. and Todd Zenger, Ph.D. will share the $10,000 honorarium in recognition of their research that examined the negative impact that social comparison, or envy, causes in the workplace. |
||
| Technology can help ease the pain when corporations change The cozy side of IT (http://news-info.wustl.edu/tips/page/normal/10353.html) Oct. 19, 2007 --
|
||
| Making R&D more cost effective New framework for developing and supporting products could improve profitability as much as 30 percent (http://news-info.wustl.edu/tips/page/normal/8883.html) March 5, 2007 --
|
||
| Study finds both drug makers and F.D.A. could run a tighter ship Pharmaceutical industry wastes $50 billion a year due to inefficient manufacturing (http://news-info.wustl.edu/tips/page/normal/7912.html) Oct. 9, 2006 --
|
||
| WUSTL business professor studies when contracting work to outside sources is a bad idea Outsourcing helps or hurts businesses, depending on how they're used (http://news-info.wustl.edu/news/page/normal/6480.html) Feb. 2, 2006 --
|
|
Showing Stories 1 through 5 of 7. - Show More |
| Clips: |
|
Showing 1 Clips. |
| Making pills the smart way
Business Week April 26, 2004 -- Despite its high-tech image, the pharmaceutical industry is less adept at manufacturing than you might expect. The Food & Drug Administration recently found hundreds of quality violations at drug companies and some factory processes are so antiquated that companies can't even pinpoint the cause of the snafus. Manufacturing may have become the poor stepchild of the pharmaceutical industry, but now, that stepchild is getting the attention it deserves. Jackson A. Nickerson of the Olin School of Business is leading an effort to find and correct flaws in drug-manufacturing practices and in FDA regulations, and he predicts huge economic gains. "Everyone has said that costs could decline by up to 50%," said Nickerson in the May 3, 2004, online issue of Business Week. |
|
Related Information Related Links:
Related Groups: |
|